(Q43976705)

28 November 2017

title

Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts (English)

1 reference

28 November 2017

0 references

1 reference

K Mizrahi

1

1 reference

28 November 2017

I Yaniv

2

1 reference

28 November 2017

S Ash

3

1 reference

28 November 2017

J Stein

4

1 reference

28 November 2017

N Askenasy

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

24 February 2014

1 reference

Bone Marrow Transplantation

28 November 2017

published in

1 reference

28 November 2017

volume

49

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

640-648

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2014.12

28 November 2017

exact match

0 references

cites work

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Immunosuppressive properties of CD95L-transduced "killer" hybrids created by fusing donor- and recipient-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

TNF-α has tropic rather than apoptotic activity in human hematopoietic progenitors: involvement of TNF receptor-1 and caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Graft versus neuroblastoma reaction is efficiently elicited by allogeneic bone marrow transplantation through cytolytic activity in the absence of GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Induction of tolerance using Fas ligand: a double-edged immunomodulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Transplantation of autologous peripheral blood progenitor cells: impact of CD34-cell selection on immunological reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Biomarkers for acute GVHD: can we predict the unpredictable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Discovery and validation of graft-versus-host disease biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Biologic markers of chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.12

Hematopoietic transplants for disease suppression and cure in type 1 diabetes

21 January 2018

1 reference

12 December 2020

Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.

1 reference

12 December 2020

Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation

1 reference

12 December 2020

Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors.

1 reference

12 December 2020

Prevention of transfusion-associated graft-versus-host disease by photochemical treatment

1 reference

12 December 2020

Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses

1 reference

12 December 2020

Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment

1 reference

12 December 2020

Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells

1 reference

12 December 2020

1 reference

12 December 2020

An essential role for NF-kappaB in human CD34(+) bone marrow cell survival.

1 reference

12 December 2020

Photochemotherapy Induces a Faster Apoptosis of Alloreactive Activated T Cells Than of Nonalloreactive Resting T Cells in Graft Versus Host Disease

1 reference

12 December 2020

A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers

1 reference

12 December 2020

Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death

1 reference

12 December 2020

Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood

1 reference

12 December 2020

Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin

1 reference

12 December 2020

Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease

1 reference

12 December 2020

Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients

1 reference

12 December 2020

Tumor necrosis factor receptors support murine hematopoietic progenitor function in the early stages of engraftment

1 reference

12 December 2020

Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.

1 reference

12 December 2020

Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion

1 reference

12 December 2020

Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators

1 reference

12 December 2020

Graft-versus-host disease

1 reference

12 December 2020

Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells

1 reference

12 December 2020

New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells

1 reference

12 December 2020

Apoptotic regulation in primitive hematopoietic precursors

1 reference

12 December 2020

Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity

1 reference

12 December 2020

Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity

1 reference

12 December 2020

Photoinactivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers

1 reference

12 December 2020

Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.

1 reference

12 December 2020

Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2014.12

1 reference

Dimensions Publication ID

28 November 2017

1038946986

0 references

Fatcat ID

release_jjlz5fi74ndjdh3jqadqzsfoqu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jjlz5fi74ndjdh3jqadqzsfoqu

24 November 2022

mapped directly with Wikidata item

1 reference